Anavex Life Sciences
Price & Volume
Stats
See moreOpen | $6.75 |
Previous Close | $6.83 |
Day Range | $6.67-$7.43 |
52W Range | $3.25-$10.45 |
Market Cap | $579.5M |
Shares Short | 17M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | $0 |
Diluted EPS | -$0.51 |
News
See moreYahoo Finance • 11 months ago
Anavex Life Sciences Reports Fiscal 2023 Year End Financial Results and Provides Business Update
Yahoo Finance • 11 months ago
Anavex Life Sciences to Announce Fiscal 2023 Year End Financial Results on Monday, November 27, 2023
Yahoo Finance • 11 months ago
Anavex Life Sciences Announces Grant of U.S. Patent Covering Blarcamesine (ANAVEX®2-73) for Treatment of Insomnia or Anxiety
Yahoo Finance • 12 months ago
Anavex Initiates Regulatory Submission of Oral Blarcamesine for Alzheimer’s Disease to European Medicines Agency (EMA)
About
CEO | Dr. Christopher U. Missling M.B.A., M.S., Ph.D. |
Address | 630 5th Avenue, New York, NY, United States, 10111 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 40 |
